Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California.


Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 13 5 2021
medline: 12 6 2021
entrez: 12 5 2021
Statut: ppublish

Résumé

With a population of forty million and substantial geographic variation in sociodemographics and health services, California is an important setting in which to study disparities. Its population (37.5 percent White, 39.1 percent Latino, 5.3 percent Black, and 14.4 percent Asian) experienced 59,258 COVID-19 deaths through April 14, 2021-the most of any state. We analyzed California's racial/ethnic disparities in COVID-19 exposure risks, testing rates, test positivity, and case rates through October 2020, combining data from 15.4 million SARS-CoV-2 tests with subcounty exposure risk estimates from the American Community Survey. We defined "high-exposure-risk" households as those with one or more essential workers and fewer rooms than inhabitants. Latino people in California are 8.1 times more likely to live in high-exposure-risk households than White people (23.6 percent versus 2.9 percent), are overrepresented in cumulative cases (3,784 versus 1,112 per 100,000 people), and are underrepresented in cumulative testing (35,635 versus 48,930 per 100,000 people). These risks and outcomes were worse for Latino people than for members of other racial/ethnic minority groups. Subcounty disparity analyses can inform targeting of interventions and resources, including community-based testing and vaccine access measures. Tracking COVID-19 disparities and developing equity-focused public health programming that mitigates the effects of systemic racism can help improve health outcomes among California's populations of color.

Identifiants

pubmed: 33979192
doi: 10.1377/hlthaff.2021.00098
pmc: PMC8458028
mid: NIHMS1732620
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

870-878

Subventions

Organisme : CDC HHS
ID : NU38OT000297
Pays : United States
Organisme : NIDA NIH HHS
ID : R37 DA015612
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003142
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

J Econ Race Policy. 2020;3(4):243-261
pubmed: 35300199
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126
pubmed: 32817602
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
JAMA. 2020 Jun 23;323(24):2478-2480
pubmed: 32391852
Health Aff (Millwood). 2020 Nov;39(11):1984-1992
pubmed: 32853056
Clin Infect Dis. 2021 Feb 16;72(4):703-706
pubmed: 32562416
N Engl J Med. 2020 Jul 16;383(3):201-203
pubmed: 32374952
Health Aff (Millwood). 2020 Jul;39(7):1253-1262
pubmed: 32437224
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S127-S135
pubmed: 32821935
N Engl J Med. 2021 Feb 25;384(8):768-773
pubmed: 33326717
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
J Infect Dis. 2020 Oct 13;222(10):1592-1595
pubmed: 32729903
Health Aff (Millwood). 2020 Nov;39(11):2010-2017
pubmed: 32970495
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045
Clin Infect Dis. 2021 Oct 5;73(7):e1814-e1821
pubmed: 33211797
Ann Intern Med. 2021 Jan;174(1):127-129
pubmed: 32692931
J Gen Intern Med. 2021 May;36(5):1476-1478
pubmed: 33604818
JAMA Netw Open. 2020 Dec 1;3(12):e2026881
pubmed: 33275153
JAMA Netw Open. 2020 Oct 1;3(10):e2025197
pubmed: 33084902
J Racial Ethn Health Disparities. 2021 Jun;8(3):732-742
pubmed: 32875535
Am J Respir Crit Care Med. 2020 Oct 1;202(7):943-949
pubmed: 32677842
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864

Auteurs

Marissa B Reitsma (MB)

Marissa B. Reitsma is a PhD student in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University, in Stanford, California. She and Anneke Claypool contributed equally to this article.

Anneke L Claypool (AL)

Anneke L. Claypool is a PhD candidate in the Department of Management Science and Engineering, Stanford University. She and Marissa Reitsma contributed equally to this article.

Jason Vargo (J)

Jason Vargo is a lead research scientist in the Climate Change and Health Equity Program, Coronavirus Sciences Branch, and the Office of Health Equity, California Department of Public Health (CDPH), in Richmond, California.

Priya B Shete (PB)

Priya B. Shete is an assistant professor in the Division of Pulmonary and Critical Care Medicine and UCSF Center for Tuberculosis, University of California San Francisco, and the COVID-19 modeling and analytics lead in the Coronavirus Sciences Branch, CDPH.

Ryan McCorvie (R)

Ryan McCorvie is a statistician in the Coronavirus Sciences Branch, CDPH.

William H Wheeler (WH)

William H. Wheeler is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

David A Rocha (DA)

David A. Rocha is a clinical informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Jennifer F Myers (JF)

Jennifer F. Myers is a senior informatics specialist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Erin L Murray (EL)

Erin L. Murray is an epidemiologist supervisor in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Brooke Bregman (B)

Brooke Bregman is a senior epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Deniz M Dominguez (DM)

Deniz M. Dominguez is a surveillance program manager in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Alyssa D Nguyen (AD)

Alyssa D. Nguyen is a research scientist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Charsey Porse (C)

Charsey Porse is an epidemiologist in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Curtis L Fritz (CL)

Curtis L. Fritz is the State Public Health Veterinarian in the Coronavirus Sciences Branch and the Division of Communicable Disease Control, CDPH.

Seema Jain (S)

Seema Jain is the chief of the Disease Investigations Section, Infectious Diseases Branch, the Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.

James P Watt (JP)

James P. Watt is the chief of the Division of Communicable Disease Control, Coronavirus Sciences Branch, and the Division of Communicable Disease Control, CDPH.

Joshua A Salomon (JA)

Joshua A. Salomon is a professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.

Jeremy D Goldhaber-Fiebert (JD)

Jeremy D. Goldhaber-Fiebert (jeremygf@stanford.edu) is an associate professor in the Centers for Health Policy and Primary Care and Outcomes Research, Stanford Health Policy, Freeman Spogli Institute for International Studies and the Stanford School of Medicine, Stanford University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH